Xueba is also open

Chapter 594 A Cross-Era Character
These few months are the most significant months in the history of anorectal development in the world.

For several months, papers with high impact factors kept refreshing the covers of major journals, and it was no surprise that the papers from the clinical trial base of Puze Hospital in China accounted for the majority.

Is bowel cancer about to be cured?
This issue is constantly being discussed frantically on major media and websites!
Since the end of the first phase of clinical trials, all major data have been analyzed and coordinated, and articles have been published. Since then, people have finally seen the efficacy of this drug.

The trade name of this drug was also officially determined after the first phase of clinical trials. It was called Puxikang.

The name is powerless to complain...

However, no matter what the name is, the clinical trials of the drug have been completed in three phases, and it has been welcomed by countless countries.

Those companies that were waiting and watching came to the door again and again, hoping to complete the negotiation with Bai Ye.

The deputy general manager of Pfizer also came to China in person, in order to openly cooperate with Bai Ye and others. Pfizer meant to directly purchase the patent right of the drug.

But the price will definitely not be lower!
This is a drug full of cross-age significance, and its appearance means the complete cure of tumors!
Saying this sentence is full of unbelievable feelings.

Can tumors be treated?

Couldn't before!

But now, it's possible!
There are many causes of bowel cancer, and the drug Puxikang mainly treats a mainstream bowel cancer, which is currently the most common bowel cancer disease.

For a while, "New England Journal of Medicine", "Lancet", "Cell"...and many other medical journals were full of research history about Puxikang, and even constantly asserted that this would be based on A great medical turning point in history.

Not only that, the editor-in-chief of the "New England Journal of Medicine" publicly wrote: "Tumor is the greatest enemy of human health at present, no one! The emergence of Puxikang is not only a cure for a disease, but the arrival of an era. The conquering of tumors will officially begin today, and I believe that there will be countless miracles in the future, and Bai Ye is the one who opened the chapter of history!"

At this time, after the publication of the New England Journal of Medicine, Bai Ye's profile picture was printed on the cover of the New England Journal of Medicine. He is completely different now. The New England Journal of Medicine is the world's most influential medical field. The journal with the highest factor, and "The Lancet" have become the gold standard of medicine.

The "Lancet" is often involved in the discussion of current affairs and politics, so the "New England Journal of Medicine" has become the most dedicated medical journal.

Being recognized by this journal means that your medical attainments have been recognized by the medical community all over the world.

And if you can be on the cover of this magazine, then congratulations, your Nobel Prize is gone!
No doubt!
This is the truth!

"New England Journal of Medicine" does have such a great charm and strength.

There are more than one Nobel Prize in Physiology or Medicine every year, but the cover of this magazine may not be able to appear on its cover in a few years. Everyone who is on the cover is a person who has made outstanding contributions to medicine.

Compared with the New England Journal of Medicine, this time the "Lancet"'s propaganda and praise for Puxikang can be described as exaggerated, and it is not too much to say that he is unscrupulous.

"The Lancet" is so daring to love and hate!
The advent of Puxikang not only represents the renewal of a drug, on the contrary, it means the renewal of an era, the birth of an industrial chain and the decline of another module.

Life, in fact, is a survival game, survival of the fittest.

With the beginning of these high-scoring medical journals, other small journals have opened up the mode of swiping and dominating the screen.

In this era of great publicity, you are not afraid of deep alleys, but you are afraid of weak wine.

As long as you have strength, your ability and influence will be infinitely expanded, how big is it?

So big that you can't recognize yourself, so big that you swell!

Therefore, there are countless people who have reached the peak and then fell to the bottom, because they are not discerning enough about themselves.

But this time, Bai Ye couldn't exaggerate it too much, because the commotion this time was really too big.

The birth of a drug means the decline of a disease, and the salvation of the expectations and lives of countless people who are suffering from the disease. This is a merit!
Bai Ye is the team leader and leader this time, and even the main developer of Puxikang drug, but the role of other people is also indispensable.

Bona, Considine, John and others once again received attention.

Considine was very happy, specially invited everyone to have a big meal, opened a bottle of expensive red wine, and gave everyone a precious gift by the way.

At the dinner table, Considine, who was already slightly drunk, said with a smile: "This time the drug Puxikang appeared, and I showed up again, and the stock of my group has been rising these days. Xiao Ye, I have to thank you very much. You, you are my rich man! If you have any research in the future, feel free to invite me, as long as you make me famous by the way."

Bai Ye suddenly realized what the old man Considine said, took out his phone, and called Boss Bai: "Hello? Old Bai, is it convenient to talk?"

"Oh? You, it's inconvenient. Hang up if you have nothing to do." Bai Donglin seemed to be busy and was about to hang up immediately.

Bai Ye: "... Has our stock price risen?"

Bai Donglin was stunned: "Why didn't it go up! Now there are rumors that Puxikang will enter Donglin Group, and now our stock has reached the point where it is hard to find a ticket, and the price is hitting a new high every day! I have already received ten Several investment companies called."

Bai Ye lowered his voice and asked, "How much is it now?"

Bai Donglin: "$68!"

Bai Ye was taken aback for a moment!
$68!

Doubled!

Compared with the original listing frenzy, it has doubled!
This is a little scary.

Bai Ye secretly calculated in his mind that his assets had doubled...

However, I don't seem to want Puxikang to enter the Donglin Group, right?

Check and Balance Group is currently planning to go public, but it is short of a hot item to go public, and Puxikang seems to be a good choice.

However, this time Puxikang's patent is not held by Bai Ye alone. Bona, Considine, John, Morstan, and Liu Yue in Boston all have a certain proportion.

(End of this chapter)